Enhanced-Affinity Anti-ECM Nanobody-Cytokine Fusions and Their Applications
Exclusively Licensed
Invention type: Technology
/
Case number: #23602
Researchers
Richard Hynes
/
Emi Lutz
/
Noor Momin
/
Noor Jailkhani
/
Karl Dane Wittrup
Departments: Department of Biology, Department of Chemical Engineering
Technology Areas: Biotechnology: Synthetic Biology / Drug Discovery and Research Tools: Antibodies / Therapeutics: Proteins & Antibodies, Small Molecules
Impact Areas: Healthy Living
-
enhanced-affinity anti-ecm nanobody-cytokine fusions and their applications
United States of America | Published application -
enhanced-affinity anti-ecm nanobody-cytokine fusions and their applications
Australia | Pending -
enhanced-affinity anti-ecm nanobody-cytokine fusions and their applications
China | Published application -
enhanced-affinity anti-ecm nanobody-cytokine fusions and their applications
India | Published application -
enhanced-affinity anti-ecm nanobody-cytokine fusions and their applications
Japan | Published application -
enhanced-affinity anti-ecm nanobody-cytokine fusions and their applications
European Patent Convention | Published application
License this technology
Interested in this technology? Connect with our experienced licensing team to initiate the process.
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.